Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

135.96
Delayed Data
As of Oct 19
 -1.21 / -0.88%
Today’s Change
96.93
Today|||52-Week Range
147.17
+17.46%
Year-to-Date

Today’s Trading

Previous close137.17
Today’s open136.89
Day’s range135.33 - 137.45
Volume5,700,001
Average volume (3 months)3,929,376
Market cap$107.3B
Dividend yield--
Data as of 4:00pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)+20.42%
Revenue growth (last year)+22.70%
P/E ratio42.2
Price/Sales8.51
Price/Book16.18

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.97+1.52%
GSKGlaxoSmithKline+0.09+0.22%
ABBVAbbVie+0.44+0.46%
SNYSanofi+0.49+0.99%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts